NO972522D0 - Monoklonale antistoffer med immunoundertrykkende aktivitet - Google Patents

Monoklonale antistoffer med immunoundertrykkende aktivitet

Info

Publication number
NO972522D0
NO972522D0 NO972522A NO972522A NO972522D0 NO 972522 D0 NO972522 D0 NO 972522D0 NO 972522 A NO972522 A NO 972522A NO 972522 A NO972522 A NO 972522A NO 972522 D0 NO972522 D0 NO 972522D0
Authority
NO
Norway
Prior art keywords
monoclonal antibodies
immunosuppressive activity
immunosuppressive
activity
monoclonal
Prior art date
Application number
NO972522A
Other languages
English (en)
Other versions
NO972522L (no
Inventor
Zoltan Nagy
Damir Vidovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO972522D0 publication Critical patent/NO972522D0/no
Publication of NO972522L publication Critical patent/NO972522L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO972522A 1994-12-07 1997-06-03 Monoklonale antistoffer med immunoundertrykkende aktivitet NO972522L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07
PCT/EP1995/004648 WO1996017874A1 (en) 1994-12-07 1995-11-25 Monoclonal antibody fragments having immunosuppressant activity

Publications (2)

Publication Number Publication Date
NO972522D0 true NO972522D0 (no) 1997-06-03
NO972522L NO972522L (no) 1997-08-06

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972522A NO972522L (no) 1994-12-07 1997-06-03 Monoklonale antistoffer med immunoundertrykkende aktivitet

Country Status (19)

Country Link
EP (1) EP0787151A1 (no)
JP (1) JP2001506122A (no)
CN (1) CN1168679A (no)
AR (1) AR002005A1 (no)
AU (1) AU4256096A (no)
BR (1) BR9509902A (no)
CA (1) CA2206471A1 (no)
CO (1) CO4480041A1 (no)
CZ (1) CZ172497A3 (no)
FI (1) FI972430A (no)
HU (1) HUT77342A (no)
IL (1) IL116228A0 (no)
MA (1) MA23739A1 (no)
NO (1) NO972522L (no)
PE (1) PE52996A1 (no)
PL (1) PL320610A1 (no)
TR (1) TR199501542A2 (no)
WO (1) WO1996017874A1 (no)
ZA (1) ZA9510195B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
AU5588099A (en) 1998-08-28 2000-03-21 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
ATE365749T1 (de) * 2000-05-12 2007-07-15 Gpc Biotech Ag Humane peptide/proteine, die das töten von zellen,einschliesslich lymphoide tumorzellen, herbeiführen oder bewirken
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
WO2003048301A2 (en) 2001-10-11 2003-06-12 Protein Design Labs Inc. Anti-hla-dr antibodies and the methods of using thereof
US7262278B2 (en) 2001-10-15 2007-08-28 Kirin Beer Kabushiki Kaisha Anti-HLA-DR antibody
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
CA2794499A1 (en) * 2010-04-01 2011-10-06 Immumomedics, Inc. Antibody-based depletion of antigen-presenting cells and dendritic cells
KR102647825B1 (ko) * 2021-07-22 2024-03-14 서울대학교산학협력단 항-hla-dp 단클론 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068790B1 (en) * 1981-06-25 1986-02-26 The Board Of Trustees Of The Leland Stanford Junior University Allele specific immunotherapeutic method and dosage form
CA2070182C (en) * 1989-12-27 2002-12-24 John Ghrayeb Chimeric immunoglobulin for cd4 receptors
DE69233628T2 (de) * 1991-07-25 2007-04-26 Biogen Idec Inc., San Diego Rekombinante Antikörper zur humanen Therapie

Also Published As

Publication number Publication date
AU4256096A (en) 1996-06-26
AR002005A1 (es) 1998-01-07
BR9509902A (pt) 1997-10-21
JP2001506122A (ja) 2001-05-15
FI972430A0 (fi) 1997-06-06
PL320610A1 (en) 1997-10-13
HUT77342A (hu) 1998-03-30
ZA9510195B (en) 1996-06-07
FI972430A (fi) 1997-06-06
TR199501542A2 (tr) 1996-07-21
NO972522L (no) 1997-08-06
IL116228A0 (en) 1996-03-31
CN1168679A (zh) 1997-12-24
CZ172497A3 (en) 1997-10-15
MX9704225A (es) 1997-09-30
EP0787151A1 (en) 1997-08-06
CO4480041A1 (es) 1997-07-09
CA2206471A1 (en) 1996-06-13
WO1996017874A1 (en) 1996-06-13
MA23739A1 (fr) 1996-07-01
PE52996A1 (es) 1996-12-12

Similar Documents

Publication Publication Date Title
PT719859E (pt) Anticorpo monoclonal anti-alfa v-integrina
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
DE69920897D1 (de) Monoklonale antikörper mit verringerter immunisierungsfähigkeit
IL128406A0 (en) Monoclonal antibodies
DK145493D0 (da) Antistof
DE69828154D1 (de) Anti-alphavbeta3 humanizierte monoklonale antikörper
ZA973664B (en) Hepatitis b monoclonal antibodies
NO972522D0 (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
NO890116L (no) Monoklonale antistoffer.
DK413389D0 (da) Monoklonale antistoffer
GB9718911D0 (en) Monoclonal antibodies
DE68912772T2 (de) Monoklonaler antikörper gegen entero-viren.
DE69427850D1 (de) Monoklonaler antikörper gegen mucoglykoprotein
NO985281D0 (no) Monoklonalt antihumant MP52-antistoff
DE69324928D1 (de) Monoklonaler antikörper
KR970043713U (ko) 2개의 주파수를 가지는 댐퍼 일체형 인슐레이터
GB9615027D0 (en) Monoclonal antibodies
BR1100555B1 (pt) anticorpos monoclonais humanizados.
IE900922L (en) Monoclonal antibody
IE901210L (en) Monoclonal antibody
BR1100504A (pt) anticorpos anti-ige.
IE900593L (en) Monoclonal antibodies
NO20000052D0 (no) Redusert fettabsorpsjon med et anti-lipase antistoff